Navigation Links
BGI Tech develops whole exome sequencing analysis of FFPE DNA samples to boost biomedicine
Date:9/18/2012

September 18, 2012, Shenzhen, China BGI Tech Solutions Co., Ltd. (the "BGI Tech"), a subsidiary company of BGI, announced today that they have achieved whole exome sequencing analysis of total degraded DNA as low as 200 ng from formalin fixed paraffin embedded (FFPE) samples. This advancement enables researchers to efficiently uncover the genetic information from FFPE disease samples such as cancers and infectious diseases, with the advantages of high reliability, accuracy and fast turnaround time.

FFPE samples are the most common biological materials for disease diagnoses and clinical studies. Especially in cancer research, millions of FFPE archival cancer tissue samples provide an enormous and invaluable repository of information, which hold a wealth of data for the discovery of biomarkers, drug development as well as diseases diagnosis and treatment.

However, during the FFPE sample preparation and storage process, the effect of formaldehyde on nucleic acids is detrimental, which can induce modification of nucleotide molecules, such as DNA damage, DNA-protein cross-links (DPC), among others. This may lay problems for researchers to get enough high-quality DNA from these FFPE samples to comprehensively explore the genetic characteristics of diseases, especially for some rare tumors.

FFPE samples are a unique sample type with a lot of challenges, and researchers from BGI Tech have optimized the DNA extraction, library construction and sequencing pipelines of FFPE DNA samples. At present, DNA as low as 200 ng from FFPE samples can be used for whole exome sequencing. To insure the accuracy and quality of sequencing, researchers evaluated the FFPE DNA sequencing results and demonstrated that FFPE exome sequencing could maintain the equivalent accuracy and reliability with the normal DNA sample sequencing.

It is reported that ~85% of genetic diseases are related with exome variations. Whole exome sequencing is a robust innovative technique that selectively sequences the coding regions of a genome and can be used to identify novel genes associated with rare and common diseases such as cancer, diabetes, and obesity. However, currently traditional exome sequencing has higher requirement for the quality and the amount of input of DNA samples. Zhao Lin, Director of Products R&D Department of BGI Tech, said, "Our whole exome sequencing technology with FFPE DNA sample is an important step toward better and quickly decoding the genetic information underlying FFPE diseases samples. I believe this advancement will strengthen the confidence of researchers in pharmaceutical and disease areas, especially when samples are limited. In order to accelerate biomedical research, we expect to conduct more FFPE sequencing projects with collaborators worldwide."


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug
2. MMV develops framework to assess risk of resistance for antimalarial compounds
3. US-Russian collaboration develops new method for sequencing dark matter of life from a single cell
4. University of Illinois professor develops tool that helps dietitians deliver info clients need and can understand
5. Pitt develops biodegradable artery graft to enhance bypass surgeries
6. MindSpec develops Autism Quiz app
7. Geneticist develops tool to identify genes important in disease, tailoring individual treatment
8. Pod corn develops leaves in the inflorescences
9. Genetic research develops tools for studying diseases, improving regenerative treatment
10. Diabetes Research Institute develops oxygen-generating biomaterial
11. Prenatal whole genome sequencing: Just because we can, should we?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Last week, Blackrock Microsystems, LLC, ... the Medical University of Warsaw, met at the Presidential Palace of the Republic ... neuroprosthetic system as part of an initiative called "Startups in the Palace – ...
(Date:9/11/2019)... ... September 09, 2019 , ... Greenberg Traurig, LLP ... J. Dykeman will speak at DeviceTalks Minnesota, Sept. 9-10, at the Hyatt Regency, ... global Life Sciences & Medical Technology Group have been featured speakers at ...
(Date:8/31/2019)... SAN FRANCISCO (PRWEB) , ... August 30, 2019 ... ... health startup making beautiful, science-backed conception essentials. Natalist empowers consumers in the preconception ... collection of essentials to support people each month that are trying to get ...
Breaking Biology News(10 mins):
(Date:9/8/2019)... ... September 05, 2019 , ... ... Fitzgerald, former Vice President of Finance for Shopify, has been named Chief Financial ... healthcare venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired Steve ...
(Date:8/29/2019)... ... 29, 2019 , ... Scientists have mapped the DNA of ... ultimately help protect the multibillion-dollar grape industry that produces juice, jelly, wine and ... alumni sequenced the microbiome found within tumors of grapevines afflicted with crown gall ...
(Date:8/27/2019)... POWAY, Calif. (PRWEB) , ... August 27, 2019 , ... ... California. She recently opened North Peninsula Veterinary Surgical Group , a new ... practice however there are plans to expand and add more veterinary specialists as the ...
(Date:8/23/2019)... , ... August 22, 2019 , ... The EnozoPro® converts ... the most harmful germs and pathogens on hard surfaces including E. Coli, Salmonella, MRSA, ... no chemical residues. For more information, visit the product page at rovingblue.com , ”At ...
Breaking Biology Technology: